Navigation Links
CCG Investor Relations Announces Company Presenters for NexGen Life Sciences Virtual Conference
Date:9/11/2013

ogy has been exclusively licensed to Bone Biologics from UCLA.

Advanced Bifurcation Systems (ABS) has developed a novel technology to enable effective stenting of coronary arteries at their branch points (bifurcations). Every year millions of patients around the world with heart disease present to doctors who find they are faced with either a PCI or CABG procedure.  A quarter of those requiring stenting will have bifurcation lesions, meaning a build-up of plaque that is blocking or about to block blood flow to the heart at a place where the blood vessel divides in two.  ABS was founded in late 2008 with the vision to facilitate the stenting of bifurcation disease so that its percutaneous treatment becomes the standard of care at bifurcated lesions.

About CCG Investor Relations
CCG is one of the nation's leading investor relations and strategic communications agencies. In business for more than 30 years, the agency provides a complete range of investor communications and counseling services to nearly 30 clients across multiple capital markets. CCG has been awarded a number of industry honors for its handling of complex investor relations and crisis communications matters. The agency's corporate headquarters is in New York with additional offices in Los Angeles, Beijing, Frankfurt, and Tel Aviv. For further information, contact CCG directly, or visit the Company's websites at http://www.ccgir.com and http://www.ccgirasia.com

About PR Newswire
PR Newswire is the premier global provider of multimedia platforms that enable marketers, corporate communicators, sustainability officers, public affairs and investor relations officers to leverage content to engage with all their key audiences. Having pioneered the commercial
'/>"/>

SOURCE CCG Investor Relations
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. BioLight Israeli Life Sciences Investments Ltd. to Webcast, Live, at RetailInvestorConferences.com on September 12th
2. Inovio Pharmaceuticals to Hold Investor Conference Call to Discuss Partnership with Roche
3. EnduRx Pharmaceuticals to Present at 2013 Rocky Mountain Life Science Investor and Partnering Conference
4. Convoy Therapeutics to Present at 2013 Rocky Mountain Life Science Investor and Partnering Conference
5. SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE MIDWEST IDEAS INVESTOR CONFERENCE
6. SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Trius Therapeutics, Inc. - TSRX
7. Advancing Research to Therapies for Brain Tumors Conference Connects Academic Scientists to Industry Investors
8. InspireMD To Participate In Benchmark Investor Conference On May 30th
9. Pacific Shore Holdings Retains Investor Relations Firm
10. Cell Therapeutics to Present at Upcoming Investor Conferences
11. ViroPharma To Participate In Two May Healthcare Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/25/2015)... , CAMBRIDGE, Mass. and ... WuXi NextCODE, which provides comprehensive capabilities for using the genome ... genetics on their publication of the largest studies of whole-genome ... today online in Nature Genetics – ... of sequence variation, authored by a team of deCODE scientists ...
(Date:3/25/2015)... Francisco, CA (PRWEB) March 25, 2015 ... Support for Novel Mechanism of Action in Neuromuscular ... 25, 2015 – Cytokinetics, Incorporated (Nasdaq: CYTK) announced ... fast skeletal muscle troponin activator tirasemtiv in the ... a Phase IIa “Evidence of Effect” or hypothesis-generating ...
(Date:3/25/2015)... the HAGUE, Netherlands , March 25, ... LES Stimulation therapy for chronic gastro-esophageal reflux disease (GERD) ... [ Surgery . 2015; 157(3):556-567 ], establishing ... therapy. The study included 25 patients ... years and taking prescribed daily proton pump inhibitor (PPI) ...
(Date:3/25/2015)... March 25, 2015  18 piglets born recently ... research by scientists in the College of Agriculture and ... a breakthrough in the field of genetic engineering. ... of Animal & Avian Sciences (ANSC) and Ki-Eun ... successfully produced genome-edited pigs using a recently developed, ...
Breaking Biology Technology:Landmark deCODE Studies Demonstrate the Power of Truly Big Genomics for Improving Medicine Worldwide 2Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 2Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 3Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 4Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 5Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 6EndoStim LES Stimulation therapy demonstrates long term safety and efficacy results in treating reflux patients 2EndoStim LES Stimulation therapy demonstrates long term safety and efficacy results in treating reflux patients 3University of Maryland Researchers Successfully Produce Genome-edited Pigs Using Revolutionary Technology 2
... Reportlinker.com announces that a new market ... catalogue: Downstream Processing ... Biologics Drives Improvement in Cost -effective ... http://www.reportlinker.com/p0316266/Downstream-Processing-in-Biopharmaceuticals---Increased-Demand-for-Biologics-Drives-Improvement-in-Cost--effective-Purification-Technologies.html Downstream ...
... from Chinese government for testing of TOGS™ 9000 ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... s = ,; var first_result; // Results are keyed by longUrl, so we need to grab the first one. ...
... Million Public Offering ... ... --> ... // Results are keyed by longUrl, so we need to grab the first one. for (var r in data.results) ...
Cached Biology Technology:Reportlinker Adds Downstream Processing in Biopharmaceuticals - Increased Demand for Biologics Drives Improvement in Cost -effective Purification Technologies 2Reportlinker Adds Downstream Processing in Biopharmaceuticals - Increased Demand for Biologics Drives Improvement in Cost -effective Purification Technologies 3Reportlinker Adds Downstream Processing in Biopharmaceuticals - Increased Demand for Biologics Drives Improvement in Cost -effective Purification Technologies 4Reportlinker Adds Downstream Processing in Biopharmaceuticals - Increased Demand for Biologics Drives Improvement in Cost -effective Purification Technologies 5Reportlinker Adds Downstream Processing in Biopharmaceuticals - Increased Demand for Biologics Drives Improvement in Cost -effective Purification Technologies 6Reportlinker Adds Downstream Processing in Biopharmaceuticals - Increased Demand for Biologics Drives Improvement in Cost -effective Purification Technologies 7Reportlinker Adds Downstream Processing in Biopharmaceuticals - Increased Demand for Biologics Drives Improvement in Cost -effective Purification Technologies 8BioSpec Global Solutions Inc hopes to receive confirmation from Chinese government for testing of TOGS™ 9000 2BioSpec Global Solutions Inc hopes to receive confirmation from Chinese government for testing of TOGS™ 9000 3BioSpec Global Solutions Inc hopes to receive confirmation from Chinese government for testing of TOGS™ 9000 4BioSpec Global Solutions Inc hopes to receive confirmation from Chinese government for testing of TOGS™ 9000 5BioSpec Global Solutions Inc hopes to receive confirmation from Chinese government for testing of TOGS™ 9000 6BioSpec Global Solutions Inc hopes to receive confirmation from Chinese government for testing of TOGS™ 9000 7OncoGenex Pharmaceuticals, Inc. Prices $50 Million Public Offering 2OncoGenex Pharmaceuticals, Inc. Prices $50 Million Public Offering 3OncoGenex Pharmaceuticals, Inc. Prices $50 Million Public Offering 4OncoGenex Pharmaceuticals, Inc. Prices $50 Million Public Offering 5OncoGenex Pharmaceuticals, Inc. Prices $50 Million Public Offering 6OncoGenex Pharmaceuticals, Inc. Prices $50 Million Public Offering 7OncoGenex Pharmaceuticals, Inc. Prices $50 Million Public Offering 8OncoGenex Pharmaceuticals, Inc. Prices $50 Million Public Offering 9
(Date:3/4/2015)... Research and Markets ( http://www.researchandmarkets.com/research/48tj8z/global_biometrics ... "Global Biometrics Market Forecast and Opportunities, 2020" ... for biometric authentication systems is projected to grow ... The driving forces for this highly ... projects and constant development in technology. In 2014, ...
(Date:3/2/2015)... , March 2, 2015  Businesses have ... Data protection company Tharon Rankins Enterprises has announced ... provides an ultra-safe way for businesses to protect ... financial transactions. Beconux is a ... Rankins Enterprises. Functioning similarly to an ATM machine, ...
(Date:2/24/2015)... This report analyzes the worldwide markets for Iris ... for the US, Canada , ... Asia-Pacific , Middle East , and ... are provided for the period 2013 through 2020. Also, a ... and analytics are derived from primary and secondary research. Company ...
Breaking Biology News(10 mins):Global Biometrics Market Forecast and Opportunities, 2020 2Global Biometrics Market Forecast and Opportunities, 2020 3Personal Data Protection Company Launches New Product 2World Iris Biometrics Industry 2World Iris Biometrics Industry 3World Iris Biometrics Industry 4World Iris Biometrics Industry 5World Iris Biometrics Industry 6World Iris Biometrics Industry 7World Iris Biometrics Industry 8World Iris Biometrics Industry 9World Iris Biometrics Industry 10World Iris Biometrics Industry 11
... three-year study to conserve and restore endangered horse mussel ... the University,s marine research and outreach centre in Portaferry ... of Biological Sciences, will provide scientific and technological research ... to restore it. Horse mussel reefs are important ...
... The Netherlands, January 22, 2009 A growing body ... delay age-related cognitive decline, including in some cases that ... in the January 2009 issue of the Journal ... of the Center for Cellular Neurobiology; Neurodegeneration Research University ...
... Current research suggests that inflammation increases the risk ... by Ovchinnikova et al, "T cell activation leads to ... appears in the February 2009 issue of The ... disease of arterial blood vessels where fats, cholesterol, blood ...
Cached Biology News:Queen's University Belfast works to save Strangford horse mussels 2Inflammation worsens danger due to atherosclerosis 2
Request Info...
Form: Ready to use Applications: ELISA...
... Strips have hydrophobic plastic supports that retain ... with toxic/hazardous solutions. Paper segments on each ... into solution. Complementary indicator charts provide clear ... in 1pH units; In packs of 100; ...
... Pharmaceutical Development, Physician Owned Labs, Drugs of Abuse, and Industrial Testing applications. Analyzer uses ... ... ... ...
Biology Products: